The impact of obesity and diabetes on the risk of disease and death due to invasive group a streptococcus infections in adults

Clinical Infectious Diseases

Volumn 62, Issue 7, 2016, Pages 845-852

  Langley, Gayle ^a   Hao, Yongping ^a   Pondo, Tracy ^a   Miller, Lisa ^b   Petit, Susan ^c   Thomas, Ann ^d   Lindegren, Mary Louise ^e   Farley, Monica M ^f   Dumyati, Ghinwa ^g   Como Sabetti, Kathryn ^h   Harrison, Lee H ⁱ   Baumbach, Joan ^j   Watt, James ^k   Van Beneden, Chris ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Colorado Department of Public Health and Environment ^*  (United States)

^c CDC   (United States)

^d OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ROCHESTER   (United States)

^h MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^k CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

more..

Author keywords

diabetes; group A Streptococcus infections; obesity

Indexed keywords

ADULT; ADULT DISEASE; AGED; ANCESTRY GROUP; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HEART DISEASE; HUMAN; INCIDENCE; INVASIVE GROUP A STREPTOCOCCUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; RISK FACTOR; UNDERWEIGHT; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; DIABETES COMPLICATIONS; HEALTH SURVEY; MICROBIOLOGY; MORTALITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84963957514     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ1032     Document Type: Article

References (39)

1. OLoughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007; 45: 853-62.
2. CDC. Group A Streptococcus. CDC Website 2013. Available at: http://www.cdc. gov/abcs/reports-findings/surv-reports.html. Accessed 2014.
3. Moreland NJ, Waddington CS, Williamson DA, et al. Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop. Vaccine. 2014; 32: 3713-20.
4. Song Y, Zhang X, Lu C, Zhang F, Zhu H. Progress in development of Group A Streptococcus vaccines. Curr Pharm Biotechnol. 2014; 14: 947-50.
5. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-41.
6. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288: 1723-7.
7. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014; 311: 806-14.
8. Geiss LS, Wang J, Cheng Y, et al. Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012. JAMA. 2014; 312: 1218-26.
9. Jain RK, Shukla R, Singh P, Kumar R. Epidemiology and risk factors for surgical site infections in patients requiring orthopedic surgery. Eur J Orthop Surg Traumatol. 2014; 8: 8.
10. Karppelin M, Siljander T, Vuopio-Varkila J, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clin Microbiol Infect. 2010; 16: 729-34.
11. Korol E, Johnston K, Waser N, et al A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS One. 2013; 8: e83743.
12. Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis. 2011; 53: 413-21.
13. Michalia M, Kompoti M, Koutsikou A, et al. Diabetes mellitus is an independent risk factor for ICU-Acquired bloodstream infections. Intensive Care Med. 2009; 35: 448-54.
14. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005; 41: 281-8.
15. Olsen MA, Higham-Kessler J, Yokoe DS, et al. Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol. 2009; 30: 1077-83.
16. Segal CG, Waller DK, Tilley B, Piller L, Bilimoria K. An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. Surgery. 2014; 29: 00272-4.
17. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Risk of community-Acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care. 2004; 27: 1143-7.
18. Tserenpuntsag B, Haley V, Van Antwerpen C, et al. Surgical site infection risk factors identified for patients undergoing colon procedures, New York state 2009-2010. Infect Control Hosp Epidemiol. 2014; 35: 1006-12.
19. Wang HE, Griffin R, Judd S, Shapiro NI, Safford MM. Obesity and risk of sepsis: a population-based cohort study. Obesity (Silver Spring) 2013; 21: E762-9.
20. Wukich DK, Crim BE, Frykberg RG, Rosario BL. Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery. J Bone Joint Surg Am. 2014; 96: 832-9.
21. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003; 26: 510-3.
22. Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999-2006. Obes Surg. 2011; 21: 351-5.
23. CDC. Active Bacterial Core surveillance methodology. 2012. Available at: http://.www.cdc.gov/abcs/index.html. Accessed 23 May 2013.
24. CDC. Introduction to emm typing: M protein gene (emm) typing Streptococcus pyogenes. 2008. Available at: http://www.cdc.gov/streplab/M-ProteinGene-Typing. html. Accessed 29 July 2015.
25. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed?. Some practical clarifications of multiple imputation theory. Prev Sci. 2007; 8: 206-13.
26. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Statist Med. 2011; 30: 377-99.
27. National Institutes of Health NH, Lung and Blood Institute. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 2000.
28. CDC. Methodologic changes in the behavioral risk factor surveillance system in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep. 2012; 61: 410-3.
29. Zhang X, Holt JB, Lu H, et al. Multilevel regression and poststratification for smallarea estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system. Am J Epidemiol. 2014; 179: 1025-33.
30. Ezzati M, Martin H, Skjold S, Vander Hoorn S, Murray CJ. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R S Med. 2006; 99: 250-7.
31. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sorensen HT, Schonheyder HC. Diabetes and outcome of community-Acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care. 2004; 27: 70-6.
32. Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003; 9: 970-7.
33. Wagner DR, Heyward VH. Measures of body composition in blacks and whites: a comparative review. Am J Clin Nutr. 2000; 71: 1392-402.
34. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006; 6: 438-46.
35. Huttunen R, Syrjanen J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2013; 37: 333-40.
36. Koh GC, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012; 31: 379-88.
37. CDC. Active bacterial core surveillance: Surveillance reports. 2014. Available at: http://www.cdc.gov/abcs/reports-findings/surv-reports.html. http://www.cdc.gov/.nchs/data/hestat/underweight-adult-07-10/underweight-adult-07-10.pdf. Accessed 17 September 2014.
38. CDC. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis. 2002; 35: 950-9.
39. Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections. Obes Rev. 2015; 10: 12320.